|1.||Zhou, Zhu-Liang: 1 article (12/2006)|
|2.||Chen, Xiang-Mei: 1 article (12/2006)|
|3.||Chen, Yi-Ping: 1 article (12/2006)|
|4.||Chen, Xiang-mei: 1 article (05/2002)|
|5.||Wei, Chen-yun: 1 article (05/2002)|
|6.||Zhang, Yan-ping: 1 article (05/2002)|
|7.||Wang, W: 1 article (12/2000)|
|8.||Chen, X: 1 article (12/2000)|
|9.||Ye, Y: 1 article (12/2000)|
|1.||IGA Glomerulonephritis (IGA Nephropathy)
12/01/2006 - "[Prospective, multi-centered, randomized and controlled trial on effect of Shenle Capsule in treating patients with IgA nephropathy of Fei-Pi qi-deficiency syndrome]."
12/01/2006 - "To observe the effect and safety of Chinese compound Shenle Capsule (SC) in treating IgA nephropathy patients of Fei-Pi qi-deficiency syndrome (FPQD). "
05/01/2002 - "To study the therapeutic effect of Shenle capsule (SLC) in treating mesangial proliferating glomerulonephritis (MsPGN) and to explore its therapeutic mechanism and clinical indication. "
05/01/2002 - "[Clinical observation on effect of shenle capsule in treating mesangial proliferating glomerulonephritis]."
12/01/2000 - "Shenle and Fragmin could significantly reduce the blood pressure, proteinuria, serum creatinine and lipids, alleviate the pathologic change of kidney tissue, decrease the type IV collagen, MMP-9 deposition. "
12/01/2000 - "After being treated with Shenle (4 g.kg-1.d-1) or Fragmin (1000 IU.kg-1.d-1) for 20 weeks, the blood pressure, proteinuria, serum creatinine, lipids, renal pathological change of remnant kidney of the model animals were examined, and the mRNA expression of MMP-9, TIMP-1 and type IV collagen in the remnant kidney were also detected. "
|1.||Collagen Type IV (Type IV Collagen)
|2.||Tissue Inhibitor of Metalloproteinase-1
|3.||Dalteparin (Dalteparin Sodium)
|4.||Messenger RNA (mRNA)